Conversely, MISP3 was identified as a protective factor, as its expression levels exhibited a decreasing trend with higher risk scores (Fig. 4 C).
← all excerpts
A disulfidptosis-related classification and risk signature identifies immunotherapy biomarkers and predicts prognosis in gastric cancer: An observational study.
1
—
—